Glycemic Response to Two Doses of Low Sugar Apple Juice - Trial NCT04747639
Access comprehensive clinical trial information for NCT04747639 through Pure Global AI's free database. This phase not specified trial is sponsored by Clinical Research Center Kiel GmbH and is currently Completed. The study focuses on Prediabetes. Target enrollment is 32 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Clinical Research Center Kiel GmbH
Timeline & Enrollment
N/A
Oct 28, 2015
Feb 01, 2021
Primary Outcome
iAUC glucose 500,iAUC insulin 500,iAUC glucose 250,iAUC insulin 250
Summary
Single center, double-blind, randomized controlled cross-over trial with four treatments and
 four time points.
 
 The study has three primary objectives. The first primary objective is to confirm the
 reduction of postprandial glycemic and insulinemic response after consumption of 500 ml
 glucose-free apple juice compared to 500 ml untreated apple juice as could be shown in a
 previous study
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04747639
Non-Device Trial